Stay updated on Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.5.2. The previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 updated for the study protocol document, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.4.2 was added, and the funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a site-wide notice about a lapse in government funding with links to cc.nih.gov and opm.gov, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedUI and editorial updates include a Show glossary control, capitalization corrections in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and an updated revision indicator to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.